Volker Diehl

发表

Prognostic factors for subdiaphragmatic involvement in clinical stage I-II supradiaphragmatic Hodgkin's disease: a retrospective analysis of the GHSG.

V. Diehl, H. Tesch, M. Sieber, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials.

V. Diehl, L. Nogova, A. Engert, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy—results of a randomized trial

G. Wassmer, B. Dörken, Y. Ko, 2003, Annals of Hematology.

Bone marrow involvement in Hodgkin's disease: an analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study Group.

V. Diehl, D. Hasenclever, E. Hiller, 1995, Journal of Clinical Oncology.

Successful mobilization of peripheral blood stem cells with the DHAP regimen (dexamethasone, cytarabine, cisplatinum) plus granulocyte colony-stimulating factor in patients with relapsed Hodgkin's disease

V. Diehl, B. Pfistner, A. Engert, 2005, Leukemia & lymphoma.

Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy alone.

R. Greil, R. Müller, N. Willich, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cologne High-Dose Sequential Chemotherapy in Relapsed and Refractory Hodgkin Lymphoma - Results of a Large Multicenter Study of the German Hodgkin Lymphoma Study Group (GHSG).

M. Sieber, J. Glossmann, B. Metzner, 2004 .

Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group.

V. Diehl, R. Fisher, D. Crowther, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG).

H. Eich, R. Müller, V. Diehl, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group.

V. Diehl, N. Schmitz, J. Franklin, 1998, Blood.

A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly).

H. Eich, V. Diehl, H. Müller-Hermelink, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group.

H. Eich, V. Diehl, A. Engert, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Fatigue in long-term survivors of Hodgkin's lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG).

V. Diehl, B. Lathan, M. Sieber, 2003, European journal of cancer.

Current clinical trials for the treatment of adult Hodgkin's disease: common strategies and perspectives.

R. Parsa-Parsi, Hans Tesch, Volker Diehl, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.